Results 251 to 260 of about 947,807 (342)

The evolving role of immunotherapy in ovarian cancer

Cancer, Volume 132, Issue 18, 15 September 2026.
Abstract Ovarian cancer remains a major cause of gynecologic cancer mortality; and, although immune checkpoint inhibitors have transformed treatment in other solid tumors, their activity in ovarian cancer has been limited by tumor heterogeneity, an immunosuppressive tumor microenvironment, and the lack of robust predictive biomarkers.
Ana Carolina Veneziani, Laura Venegas, Amit M. Oza   +2 more
wiley   +1 more source

Annual Report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2023 and Annual Treatment Report for 2018. [PDF]

J Obstet Gynaecol Res
Kajiyama H, Tamauchi S, Takahashi F, Satoh T, Board members of the 2025 Committee on Gynecologic Oncology of the Japan Society of Obstetrics and Gynecology.   +4 more
europepmc   +1 more source

Mental Health Conditions and Incident Cancer: A Prospective Cohort Study of 402,255 UK Biobank Participants

International Journal of Cancer, Volume 159, Issue 6, Page 1420-1431, 15 September 2026.
Evidence suggests a potential association between mental health conditions and cancer risk, yet previous studies were limited by small samples and the use of self‐reported measures. Using data from the UK Biobank's large‐scale prospective population cohort over a median follow‐up of 13.4 years, this analysis demonstrates associations between depression,
Mohammed Sherif Amin, Solange Parra‐Soto, Ziyi Zhou, Shinya Nakada, Ike Dhiah Rochmawati, Carlos Celis‐Morales, Nancy Meligy, Jill P. Pell, Frederick K. Ho   +8 more
wiley   +1 more source

Endometrial Hemangiomatous Polyp Presenting as Postmenopausal Bleeding and Mimicking Uterine Malignancy: A Rare Diagnostic Challenge. [PDF]

J Midlife Health
Jindal A, Soni A, Kapatia G, Rana MK.
europepmc   +1 more source

Inpatient Exposure, Confidence, and Knowledge in Pediatric Hematology/Oncology: Evaluating General Pediatric Residents During 2025 ACGME Curriculum Change

Pediatric Blood &Cancer, Volume 73, Issue 9, September 2026.
ABSTRACT Background General pediatricians often evaluate hematologic and oncologic presentations before subspecialty consultation, yet the 2025 Accreditation Council for Graduate Medical Education (ACGME) pediatric requirements reduce inpatient pediatric hematology/oncology (PHO) time, raising questions about resident readiness.
Colburn Yu, Rohini Jain
wiley   +1 more source

Giant mucinous ovarian cyst filling the abdominal cavity: clinical presentation, imaging findings, and surgical management. [PDF]

BMC Womens Health
Karakaya H, Gümüş M, Akarsu GD.
europepmc   +1 more source

CCDC80 suppresses high‐grade serous ovarian cancer migration via negative regulation of B7‐H3

Molecular Oncology, Volume 20, Issue 9, Page 2262-2279, September 2026.
PAX8 is a lineage‐specific master regulator of transcription in high‐grade serous ovarian cancer (HGSC) progression. We show for the first time that PAX8 facilitates proliferation and metastasis by repressing the cell autonomous tumor suppressor CCDC80 and inducing B7‐H3 expression.
Aya Saleh, Nitzan Medina‐Itzhaki, Milena Chekov, Eden Gal‐Swisa, Roba Gabesh‐Wahabi, Inbar Savyon, Inna Naroditsky, Hilary A. Kenny, Basem Fares, Lina Korsensky, Einav Girsh, Liron Berger, Ruth Perets   +12 more
wiley   +1 more source

Genetic-Epigenetic Interactions in Uterine Leiomyomas: <i>MED12</i> Mutations as Predictors of Aberrant DNA Methylation. [PDF]

Genes (Basel)
Kazmi T, Nangrejo R, Abbas E, Waris N, Siddiqui IA, Rehman R, Laurance-Young P.   +6 more
europepmc   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

Molecular Oncology, Volume 20, Issue 9, Page 2188-2202, September 2026.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena, Karin Teien Lande, Eva Diaz, Ana Vilar, Juan Cueva, Efigenia Arias, Victoria Sampayo, Alicia Abalo, Nerea González, Eva Colás, Antonio Gil‐Moreno, Miguel Abal, Gema Moreno‐Bueno, Therese Sørlie, Kristina Lindemann, Laura Muinelo‐Romay   +15 more
wiley   +1 more source

Exploratory Preoperative Risk Stratification of Uterine Mesenchymal Tumors in Postmenopausal Women with Complementary Transcriptomic Analysis. [PDF]

Diagnostics (Basel)
Wan X, Zhang T, Li J, Song Z, Ruan F, Luo J.   +5 more
europepmc   +1 more source